Literature DB >> 22420292

The risk of passive regurgitation during general anaesthesia in a population of referred dogs in the UK.

Cecilia Lamata1, Verity Loughton, Monie Jones, Hatim Alibhai, Elizabeth Armitage-Chan, Karen Walsh, David Brodbelt.   

Abstract

OBJECTIVE: To evaluate the risk of passive regurgitation during anaesthesia, and to identify major factors associated with this in dogs attending the Queen Mother Hospital for Animals (QMHA), the Royal Veterinary College. STUDY
DESIGN: A case-control study nested within the cohort of dogs undergoing anaesthesia with inhalation agents. ANIMAL POPULATION: All dogs undergoing general anaesthesia at the referral hospital between October 2006 and September 2008 (4271 cases).
METHODS: All dogs anaesthetized at the QMHA during the study period were included. Regurgitating cases were defined as dogs for which reflux material was observed at the external nares or in the mouth, either during anaesthesia or before return to normal consciousness immediately after general anaesthesia. The risk of regurgitation was estimated and risk factors for regurgitation were evaluated with multivariable logistic regression (p < 0.05).
RESULTS: The overall risk of regurgitation was 0.96% (41 cases out of 4271 anaesthetics, 95% confidence interval [95% CI] 0.67-1.25%). Exclusion of animals where pre-existing disease was considered a contributing factor to regurgitation (n = 14) resulted in a risk of passive regurgitation of 0.63% (27 cases of 4257 anaesthetics, 95% CI 0.40-0.87%). In the multivariable logistic regression model, procedure and patient weight were significantly associated with regurgitation. Dogs undergoing orthopaedic surgery were 26.7 times more likely to regurgitate compared to dogs undergoing only diagnostic procedures. Dogs weighing more than 40 kg were approximately five times more likely to regurgitate than those weighing <20 kg. CONCLUSIONS AND CLINICAL RELEVANCE: This study highlights the rare but important occurrence of perioperative regurgitation and identifies that dogs undergoing orthopaedic procedures, and those weighing more than 40 kg, are particularly at risk. Further work is required to evaluate the reasons for these observations.
© 2012 The Authors. Veterinary Anaesthesia and Analgesia. © 2012 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesiologists.

Entities:  

Mesh:

Year:  2012        PMID: 22420292     DOI: 10.1111/j.1467-2995.2011.00704.x

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  5 in total

1.  Computed tomographic features of gastric and esophageal content in dogs undergoing CT myelography and factors influencing the presence of esophageal fluid.

Authors:  Caroline Benzimra; Ilaria Cerasoli; Delphine Rault; Karine Chalvet-Monfray; Eddy Cauvin; Laurent Couturier; Laure Gatel
Journal:  J Vet Sci       Date:  2020-11       Impact factor: 1.672

2.  The Effect of the Preoperative Fasting Regimen on the Incidence of Gastro-Oesophageal Reflux in 90 Dogs.

Authors:  Paraskevi Tsompanidou; Joris H Robben; Ioannis Savvas; Tilemahos Anagnostou; Nikitas N Prassinos; George M Kazakos
Journal:  Animals (Basel)       Date:  2021-12-29       Impact factor: 2.752

Review 3.  Factors Affecting Intraoperative Gastro-Oesophageal Reflux in Dogs and Cats.

Authors:  Ioannis Savvas; Kiriaki Pavlidou; Tilemachos Anagnostou; Eugenia Flouraki; George Kazakos; Dimitrios Raptopoulos
Journal:  Animals (Basel)       Date:  2022-01-20       Impact factor: 2.752

4.  The Effect of Premedication on the Incidence of Gastroesophageal Reflux in 270 Dogs Undergoing General Anesthesia.

Authors:  Eugenia S Flouraki; Ioannis Savvas; George Kazakos; Tilemahos Anagnostou; Dimitrios Raptopoulos
Journal:  Animals (Basel)       Date:  2022-10-04       Impact factor: 3.231

Review 5.  A Systematic Review of the Methods of Assessment of Gastro-Oesophageal Reflux in Anaesthetized Dogs.

Authors:  Anna Carolina Fernandez Alasia; Olivier Levionnois; Mathieu Raillard
Journal:  Animals (Basel)       Date:  2021-03-18       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.